| Ytd | -18.22% | |
| 1y | -43.26% |
| Open | 34.48 | Prev Close | 34.07 | Low | 33.27 | High | 35.38 | Mkt Cap | 595.99M |
| Vol | 0.00 | Avg Vol | 151.39K | EPS | -17.01 | P/E | -2.06 | Forward P/E | N/A |
| Beta | 0.58 | Short Ratio | 5.04 | Inst. Own | 87.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 28.83 | 200-d Avg | 30.54 | 1yr Est | 70.50 |
Claritev Corp (NYSE:CTEV) on Friday reported better-than-expected second-quarter financial results a
CTEV reported better-than-expected Q2 results and raised FY26 sales guidance. Analysts maintain Buy
Citigroup analyst Daniel Grosslight maintains Claritev (NYSE:CTEV) with a Buy and raises the pric
Canaccord Genuity analyst Richard Close maintains Claritev (NYSE:CTEV) with a Buy and raises the
Claritev NYSE: CTEV reported second-quarter revenue growth, record bookings and higher cash flow, pr
Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript
Claritev Corporation (CTEV) came out with a quarterly loss of $3.49 per share versus the Zacks Conse
Claritev (NYSE:CTEV) raises FY2026 sales outlook from $985.000 million-$1.000 billion to $1.000 bill
Claritev (NYSE:CTEV) reported quarterly losses of $(3.49) per share which beat the analyst consensus
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a tec
Claritev Corporation (âClaritevâ or the âCompanyâ) (NYSE: CTEV), a technology, data, and ins
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a tec
Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on ma
MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #HealthcareAffordability--Claritev Corporation (NYSE: CTEV),
New solution combines claims-informed intelligence with AI-powered financial guidance to help employ
Claritev will use CodeTogether's AITrax to help measure adoption, cost, quality, and value across it
Canaccord Genuity analyst Richard Close maintains Claritev (NYSE:CTEV) with a Buy and raises the
WELLESLEY, Mass. and MCLEAN, Va., July 16, 2026 /PRNewswire/ -- Sun Life U.S., a leading provider of
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a hea
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (NYSE: CTEV), a technology, data, and insights co
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a tec
As stated in the Form 8-K filed on May 18, 2026, in August 2024 Claritev Corporation (the "Compa
Claritev Cares, the charitable foundation established by Claritev (NYSE: CTEV), and the Elizabeth Do
MCLEAN, Va. & WASHINGTON--(BUSINESS WIRE)---- $CTEV #ClaritevCares--Claritev Cares, the charitable f
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered L
Canaccord Genuity analyst Richard Close initiates coverage on Claritev (NYSE:CTEV) with a Buy rat
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investi
Smart credit team Ares Mgmt bought discounted BDCs aggressively in Q1 2026. They're not guessing
An article published on Thursday, May 14, 2026 alleges that "DOJ launches criminal antitrust pro
Claritev (NYSE:CTEV) raises FY2026 sales outlook from $980.000 million-$1.000 billion to $985.000 mi
Claritev (NYSE:CTEV) reported quarterly losses of $(4.41) per share which missed the analyst consens
Barclays analyst Glen Santangelo initiates coverage on Claritev (NYSE:CTEV) with a Overweight rat
Wells Fargo analyst Stan Berenshteyn maintains Claritev (NYSE:CTEV) with a Equal-Weight and lower
Citigroup analyst Daniel Grosslight maintains Claritev (NYSE:CTEV) with a Buy and lowers the pric
Guggenheim analyst Jason Cassorla maintains Claritev (NYSE:CTEV) with a Buy and lowers the price
Wells Fargo analyst Stan Berenshteyn maintains Claritev (NYSE:CTEV) with a Equal-Weight and lower
Claritev (NYSE:CTEV) reported quarterly losses of $(4.88) per share which missed the analyst consens
Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a technology, data
Citigroup analyst Daniel Grosslight maintains Claritev (NYSE:CTEV) with a Buy and lowers the pric